Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arcutis Biotherapeutics, Inc. (ARQT)  
$8.00 0.60 (6.98%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 106,469,000
Market Cap: 851.75(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.84 - $14.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 8
Insider 6 Months    : 8
Insider 3/6 Months : 16.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with unmet medical needs. Co.'s product candidate, topical roflumilast cream, is used for plaque psoriasis, including intertriginous psoriasis, as well as atopic dermatitis. Co. is developing a topical foam formulation of roflumilast for the treatment of scalp psoriasis and seborrheic dermatitis; ARQ-252, a topical cream formulation of a small molecule inhibitor of Janus kinase type 1 for chronic hand eczema and vitiligo; and ARQ-255, an alternative topical formulation of ARQ-252 designed to reach into the skin in order to treat alopecia areata.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 21,052 21,052 102,515 352,515
Total Buy Value $199,994 $199,994 $409,328 $5,409,328
Total People Bought 1 1 2 2
Total Buy Transactions 1 1 3 4
Total Shares Sold 29,378 32,553 35,988 495,179
Total Sell Value $325,434 $333,787 $359,367 $9,817,049
Total People Sold 4 4 4 10
Total Sell Transactions 5 7 9 54
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 194
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Welgus Howard G. Director   –       •      –    2022-05-02 4 OE $0.58 $2,555 D/D 2,500 184,396     -
   Osborne David W Chief Technical Officer   •       –      –    2022-04-21 4 AS $20.42 $44,872 D/D (2,197) 257,229 33%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2022-04-08 4 S $20.71 $4,142,000 I/I (200,000) 451,086 -22%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2022-04-07 4 S $20.66 $7,127,617 I/I (344,996) 553,886 -26%     
   Orbimed Capital Gp Vii Llc 10% Owner   –       –       •   2022-04-06 4 S $20.69 $6,893,991 I/I (333,204) 731,082 -21%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-04-05 4 AS $21.43 $21,430 D/D (1,000) 659,667 18%     
   Welgus Howard G. Director   –       •      –    2022-04-01 4 AS $20.02 $150,184 D/D (7,500) 181,896 22%     
   Welgus Howard G. Director   –       •      –    2022-04-01 4 OE $0.58 $4,352 D/D 7,500 189,396     -
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-23 4/A OE $6.52 $99,958 D/D 15,331 46,444     -
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-23 4/A OE $6.52 $165,139 D/D 25,328 56,441     -
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-23 4 A $6.52 $165,139 D/D 25,328 56,441     -
   Watanabe Todd Franklin President and CEO   •       •      –    2022-03-09 4 AS $17.00 $5,100 D/D (300) 660,667 46%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-03-07 4 AS $16.44 $13,125 D/D (770) 660,967 47%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-03-07 4 OE $1.68 $1,176 D/D 700 661,667     -
   Burrows Scott L Chief Financial Officer   •       –      –    2022-03-07 4 AS $16.44 $164 D/D (10) 35,256 47%     
   Osborne David W Chief Technical Officer   •       –      –    2022-03-07 4 AS $16.44 $460 D/D (28) 259,426 47%     
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-07 4 AS $16.44 $493 D/D (30) 31,113 47%     
   Lock Kenneth A. Chief Commercial Officer   •       –      –    2022-03-07 4 AS $16.44 $493 D/D (30) 44,011 47%     
   Burnett Patrick See Remarks   •       –      –    2022-03-07 4 AS $16.44 $493 D/D (30) 43,039 47%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-03-04 4 AS $16.86 $41,962 D/D (2,489) 661,037 43%     
   Burrows Scott L Chief Financial Officer   •       –      –    2022-03-04 4 AS $16.86 $4,940 D/D (293) 35,266 43%     
   Osborne David W Chief Technical Officer   •       –      –    2022-03-04 4 AS $16.86 $13,959 D/D (828) 259,454 43%     
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-04 4 AS $16.86 $16,741 D/D (993) 31,143 43%     
   Lock Kenneth A. Chief Commercial Officer   •       –      –    2022-03-04 4 AS $16.86 $16,741 D/D (993) 44,041 43%     
   Burnett Patrick See Remarks   •       –      –    2022-03-04 4 AS $16.86 $16,539 D/D (981) 43,069 43%     
  194 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us